A live, genetically modified, canarypox virus vaccine has been given the green light to protect horses in New Zealand if there is a outbreak of equine influenza. If used, it will be the first time a genetically modified organism has been released into the environment. The Environmental Risk Management Authority (Erma) has approved an application by the Racing Board and Equine Health Association to use the vaccine under certain conditions.